Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
about
Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strainsPromising oncolytic agents for metastatic breast cancer treatmentPreclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcomaCorrelates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates.Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models.Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strainsCombination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent.Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival.Vaccinia virus-mediated expression of human erythropoietin in tumors enhances virotherapy and alleviates cancer-related anemia in mice.Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy.Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine.
P2860
Q21132553-9661A1FC-8C50-40A3-88BB-E144C5F5DF8AQ26830620-13105EA4-9101-4B6C-BE70-37E19353C3C0Q28729948-4B16645D-5460-476C-A34B-6FFB5AEB6C37Q33587040-33689B7D-DDBB-4C98-9E17-20247A516C42Q34142957-4B59F44E-1081-4442-B7A5-04E54E0ABE31Q34262005-7E1AEC8E-B2EE-429C-828B-69D575D70FF0Q34348199-70C5D55D-DFD4-4948-8110-63B2B827713BQ35868856-795B4D4D-E773-4946-B261-0E53D4870626Q38194135-A750B01E-F1EB-4D34-A291-0E024A7460A4Q39135169-9B6FFBD0-C8F9-47A0-B354-F21F5DA4886DQ39139854-67EF947B-9C71-4070-8721-90434E9C8748Q39961077-E2FBC000-D39E-4093-9F95-35BF69BC5794Q40162348-7683292A-F972-4D66-9892-C085EAEB920C
P2860
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@ast
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@en
type
label
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@ast
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@en
prefLabel
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@ast
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@en
P2093
P2860
P356
P1476
Replication efficiency of onco ...... nd antitumor efficacy in mice.
@en
P2093
Nanhai G Chen
Qian Zhang
P2860
P2888
P356
10.1186/1479-5876-9-164
P577
2011-09-27T00:00:00Z
P5875
P6179
1007378160